Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Aluminum-based antacids such as aluminum hydroxide bind dietary phosphate in the gut into an insoluble salt that is passed in stool, and with prolonged or high-dose use this can drop blood phosphate low enough to impair bone mineralization, leading to osteomalacia, bone pain, muscle weakness, and fractures. Absorbed aluminum can also deposit at the bone mineralization front and directly suppress bone-building cells, a risk that climbs sharply in people with reduced kidney function, those on dialysis, and anyone eating a low-phosphate diet. Several factors affect who is at risk and how fast problems develop, so see below for the important details before making any changes
If you rely on over-the-counter antacids for persistent heartburn or indigestion, it’s important to understand how chronic use of aluminum hydroxide can affect your body. One key issue is chronic antacid aluminum hydroxide phosphate depletion, which can lead to low phosphate levels and weakened bones over time. This article explains how and why this happens, what signs to watch for, and how to protect your health.
Aluminum-based antacids (commonly aluminum hydroxide) relieve acid symptoms by:
While effective for short-term relief, aluminum compounds draw in certain nutrients—especially phosphate—from your diet.
Phosphate is an essential mineral that:
In the gut, aluminum ions from antacids bind free dietary phosphate to form aluminum phosphate. This complex is not absorbed, so both aluminum and phosphate are excreted. Over weeks or months of frequent antacid use, this can lead to a steady drop in blood phosphate levels.
When phosphate levels stay low for an extended period, your body struggles to maintain normal bone structure. Key issues include:
Chronic antacid aluminum hydroxide phosphate depletion may also contribute to other health concerns:
While anyone can experience phosphate depletion with long-term, high-dose antacid use, certain groups are more vulnerable:
Early phosphate depletion can be subtle. Watch for:
If you experience these symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Review Your Antacid Use
Monitor Dietary Phosphate
Consider Supplementation
Routine Lab Checks
Adopt Bone-Healthy Habits
Phosphate depletion and early bone softening may not be immediately obvious. Contact a healthcare professional if you have:
For a quick, confidential check of your symptoms, try the free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a helpful first step but not a substitute for professional evaluation.
Always discuss any serious or persistent symptoms with your healthcare provider. They can:
Prompt treatment can halt or reverse bone softening and prevent complications.
By staying informed and proactive, you can enjoy effective relief from heartburn without compromising your bone health. If in doubt, reach out to a trusted healthcare professional for personalized advice.
(References)
* Saadeh G, Bauer T, Licata A, Sheeler L. Antacid-induced osteomalacia. Cleve Clin J Med. 1987 May-Jun;54(3):214-6. doi: 10.3949/ccjm.54.3.214. PMID: 3608134.
* Vanderlinde RE, Kowalski P. The clinical biochemistry of phosphorus. Clin Biochem. 1971 Jun;4(2):76-88. doi: 10.1016/s0009-9120(71)90752-1. PMID: 4942746.
* Janson C, Birnbaum G, Baker FJ 2nd. Hypophosphatemia. Ann Emerg Med. 1983 Feb;12(2):107-16. doi: 10.1016/s0196-0644(83)80387-4. PMID: 6337531.
* Knochel JP. Hypophosphatemia. West J Med. 1981 Jan;134(1):15-26. PMID: 7010790; PMCID: PMC1272444.
* Boutsen Y, Devogelaer JP, Malghem J, Noel H, Nagant de Deuxchaisnes C. Antacid-induced osteomalacia. Clin Rheumatol. 1996 Jan;15(1):75-80. doi: 10.1007/BF02231691. PMID: 8929782.
* De Clerck LS. Crystal arthropathies. Acta Clin Belg. 1997;52(6):394-400. doi: 10.1080/17843286.1997.11718606. PMID: 9489136.
* Megapanou E, Florentin M, Milionis H, Elisaf M, Liamis G. Drug-Induced Hypophosphatemia: Current Insights. Drug Saf. 2020 Mar;43(3):197-210. doi: 10.1007/s40264-019-00888-1. PMID: 31776845.
* Younis NK, Maktabi MAN, Jdiaa SS, Koubar SH. A case of severe hypophosphatemia. J Nephrol. 2021 Dec;34(6):2117-2121. doi: 10.1007/s40620-020-00963-2. Epub 2021 Jan 27. PMID: 33502727.
* Doshi P, Hong K, Jefferson T, Jones M, Rowhani-Farid A. Control vaccine formulation. Lancet. 2021 Mar 20;397(10279):1061-1062. doi: 10.1016/S0140-6736(21)00382-2. PMID: 33743866.
* Kooijman S, Vrieling H, Verhagen L, de Ridder J, de Haan A, van Riet E, Heck AJR, Kersten GFA, Pennings JLA, Metz B, Meiring HD. Aluminum Hydroxide And Aluminum Phosphate Adjuvants Elicit A Different Innate Immune Response. J Pharm Sci. 2022 Apr;111(4):982-990. doi: 10.1016/j.xphs.2022.01.014. Epub 2022 Jan 26. PMID: 35090866.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.